Fed. Circ. Revives Astellas Patent Axed As Natural Law

The Federal Circuit on Wednesday vacated a lower court's invalidation of an Astellas Pharma overactive bladder medication patent for claiming only a natural law, saying the holding was improper because the...

Already a subscriber? Click here to view full article